BioNTech SE American Depositary ShareBNTX
Close of Friday, October 23, 2026 · BioNTech SE American Depositary Share is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$88.11
vs its Pivot
-9.6%
OnlyAlpha Score
34
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -11.2% | -7.4% | -17.1% | -2.3% | -18.5% |
No dividend in the last 12 months.
Who runs and owns it
Run by Ugur Sahin, Struengmann brothers (co-founder CEO; controlling holders), one of the Forbes billionaires.
In these funds
IBB · 0.67%
Big investors that own it (latest 13F)
| Temasek | 0.4% of holdings |
| Baker Bros. Advisors | 0.1% of holdings |
Suppliers, customers and partners
Partners and deals
| Pfizer | COMIRNATY; 50/50 dev cost share |
| Bristol Myers Squibb | pumitamig (BNT327) |
From the companies' own annual reports filed with the SEC.
Healthcare · Biotech
Get BNTX in your free daily emailAfter every close: whether BNTX is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track BNTX free → Full Stock check
Track BNTX free → Full Stock check